{"id":"NCT00889252","sponsor":"Vistakon Pharmaceuticals","briefTitle":"Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers","officialTitle":"A Single-Center, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group Study Evaluating the Safety of a Novel Contact Lens Used Daily in Healthy, Normal Volunteers","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-04","primaryCompletion":"2009-07","completion":null,"firstPosted":"2009-04-28","resultsPosted":"2010-11-23","lastUpdate":"2015-03-06"},"enrollment":250,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Allergic Conjunctivitis"],"interventions":[{"type":"DEVICE","name":"contact lens with ketotifen","otherNames":[]},{"type":"DEVICE","name":"contact lens","otherNames":[]}],"arms":[{"label":"K-Lens","type":"EXPERIMENTAL"},{"label":"Placebo Lens","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the safety of a novel contact lens in healthy normal volunteers.","primaryOutcome":{"measure":"Lid and Lid Margin Erythema, Change From Baseline","timeFrame":"baseline and 12 weeks","effectByArm":[{"arm":"K-Lens","deltaMin":0,"sd":0},{"arm":"Placebo Lens","deltaMin":0,"sd":0}],"pValues":[]},"eligibility":{"minAge":"8 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":168},"commonTop":["Instillation Site Irritation"]}}